Vaccine News

Vaccine news brought to you by Precision Vaccinations.

Jun 22, 2025 • 2:57 pm CDT
Maps June 22, 2025

The World Health Organization states that for nearly a decade, the Horn of Africa has been battling persistent outbreaks of the poliovirus variant. Low immunity in children and unmonitored population movement have fueled the spread of poliovirus.

For example, the Federal Democratic Republic of Ethiopia recently reported four additional cases of circulating vaccine-derived polioviruses (cVDPVs) from Oromiya.

According to the Global Polio Eradication Initiative GPEI), on June 18, 2025, Ethiopia reported 33 cases reported in 2025.

This GPEI data compares with 43 cases reported in 2024.

The Global Polio Surveillance Action Plan 2025–2026 outlines enhanced strategies for acute flaccid paralysis and response to poliovirus transmission.

In 2025, Ethiopia strengthened its surveillance and preparedness efforts to prevent the further spread of the disease. In February, over 15 million children were vaccinated. The campaign launched in the country’s Somali region.

To alert international travelers to the risk of poliovirus in Ethiopia, the U.S. Centers for Disease Control and Prevention (CDC) included this African country in the June 14, 2025, Travel Health Advisory.

The CDC recommends that all visitors to high-risk areas be fully immunized against this severe disease. Polio vaccines are generally available at travel clinics and pharmacies throughout the United States.

Jun 22, 2025 • 9:55 am CDT
WHO June 2025

The World Health Organization (WHO) recently published the 27th Emergency Situational Update regarding cholera outbreaks.

The WHO reported that from January 2025 to May 25 2025, a cumulative total of 211,678 cholera cases and 2,754 related fatalities were reported from 26 countries.

Three WHO regions, with the African Region recording the highest numbers, followed by the Eastern Mediterranean Region, and the South-East Asia Region.

In May 2025, the South-East Asia Region reported 257 new cholera cases from Myanmar.

Since cholera is a vaccine-preventable disease, the WHO recommends oral cholera vaccines (OCVs) for travelers visiting countries where outbreaks are occurring.

As of June 22, 2025, the WHO has prequalified Vaxchora®, Dukoral®, Shanchol™, Euvichol®, and Euvichol-S OCVs.

In January 2025, the WHO stated that OCV production had reached 6.2 million doses. However, as of May 2025, the OCV stockpile consisted of 5.7 million doses, which is below the minimum emergency threshold of five million.

The WHO says that, during the current cholera outbreak, only one OCV dose course has been implemented in reactive vaccination campaigns.

As of June 22, 2025, there are ample supplies of OCVs at travel clinics and pharmacies in the United States.

Jun 20, 2025 • 2:02 pm CDT
Google Maps June 20, 2025

In the European Union/European Economic Area (EU/EEA), several countries are currently experiencing outbreaks of hepatitis A virus (HAV), with two clusters involving closely related HAV subgenotype IB strains.

As of June 18, 2025, Hungary (66 cases), Austria (43 cases), Slovakia (23 cases) and Germany (three cases) have a high probability of sustained transmission and circulation of the HAV within specific groups, as assessed by the European Centre for Disease Prevention and Control (ECDC).

Additionally, cases have been reported among members of the Roma communities in Czechia.

In 2024, Czechia sequenced a total of 52 samples, of which 34 were identified as subgenotype IB. Between January and the end of April 2025, 30 additional samples were analysed, with 25 identified as subgenotype IB.

Since hepatitis A is a vaccine-preventable disease, the ECDC recommends tailoring outreach to populations at higher risk of exposure to HAV, based on an understanding of their specific needs, attitudes, and knowledge.

The specific recommendations include the following actions:

Targeted single-dose pre-exposure hepatitis A vaccination programmes for populations who are not vaccinated and who are more likely to be exposed to the virus.

Provide post-exposure prophylaxis to close contacts of cases by administering the hepatitis A vaccine, or in particular circumstances, hepatitis A immunoglobulins.

And finally, consider targeted vaccination of population groups more likely to be exposed to HAV in low and very-low-endemicity settings to provide individual health benefits.

As of June 20, 2025, the U.S. CDC recommends that international travelers visiting areas with HAV outbreaks consult with a vaccine expert one month before departure to assess vaccination options.

For example, vaccination is recommended for unvaccinated travelers one year old or older going to Hungary. And when visiting the Lisbon and Tagus Valley regions in Portugal

Jun 20, 2025 • 1:01 pm CDT
Google Maps June 20, 2025

According to a recent World Health Organization report, the Western Pacific Region is facing significant dengue outbreaks for the second consecutive year. 

Since dengue is a vaccine-preventable disease, countries such as the Republic of Singapore are conducting clinical trials pursuing the use of a third-generation vaccine.

On June 18, 2025, MSD (Merck & Co.) announced the initiation of the MOBILIZE-1 Phase 3 clinical trial (V181-005) evaluating the safety, immunogenicity and efficacy of a single dose of V181, a quadrivalent vaccine candiate, for the prevention of dengue disease caused by any of the four dengue virus serotypes, regardless of prior dengue exposure.

Recruitment for this late-stage trial has begun, and the first participants are now enrolling in Singapore.

The study is planned to include more than 30 trial sites in dengue-endemic areas in the Asia-Pacific region, including Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam.

Dr. Abdullahi Sheriff, Managing Director, MSD in Singapore, Malaysia & Brunei, commented in a press release, “We are grateful to the scientific community in Singapore for their commitment to scientific excellence and partnership throughout this journey."

"Singapore and the surrounding countries in Southeast Asia are areas with a risk for dengue, making it a serious public health threat."

Throughout 2024 and during the first half of 2025, dengue cases and related fatalities have been reported in most countries in the Region of the Americas, including the United States. 

The global need for additional dengue vaccines is substantial. As of June 20, 2025, the second-generation QDENGA vaccine is in limited supply worldwide and is unavailable in the U.S.

Jun 19, 2025 • 3:39 pm CDT
US CDC June 2025

The World Health Organization (WHO) today reported rabies cases in dogs continue to be reported from multiple municipalities in the Democratic Republic of Timor-Leste during 2025.

As of June 18, 2025, the WHO's 12th Edition reported six human rabies cases between April 2024 and June 15, 2025, in a Southeast Asian country. 

Five of these cases have been fatal. Among those cases, three deaths were recorded in Oecusse, and one each in Ermera and Bobonaro municipalities.

Out of 1,445 dog bite cases reported between April 2024 and June 2025, 41% were classified as category III, considered high-risk and for which immediate vaccination and administration of rabies immunoglobulin are recommended.

However, only 18% of those category III cases have received immunoglobulin. But 66% of all bite victims received an initial rabies vaccination after exposure, but most have not completed the full recommended course.

The Ministry of Health of Timor-Leste, in collaboration with stakeholders and the public, has confirmed that it will launch a national rabies prevention campaign aimed at increasing vaccine availability, expanding vaccination of dog populations, and enhancing surveillance in both human and animal populations.

The U.S. CDC advises that you should consult with a healthcare provider to determine whether you should receive a pre-exposure vaccination before visiting Timor-Leste in 2025.

In addition to rabies, measles, typhoid, and chikungunya vaccinations should be considered before visiting Timor-Leste.

 

Jun 19, 2025 • 2:25 pm CDT
2025

The International Air Transport Association (IATA) recently confirmed that many air travelers fail to realize that defying the crew's instructions not only puts everyone's safety at risk but also poses a significant liability for airlines.

IATA figures indicate an increase in the rate of reported unruly passenger incidents.

Based on over 24,500 incident reports from more than 50 operators globally, there was one incident for every 480 flights in 2023, compared to one incident for every 568 flights in 2022.

To address one aspect of these concerns, the Türkiye Cumhuriyeti issued a warning on May 6, 2025, stating that potential disciplinary action may be taken against airline passengers who stand up before the plane has come to a complete stop and the seatbelt sign has been turned off.

The "Passenger Announcements Circular" No. UOD - 2025/01 empowers Turkish Airlines, the country's flag carrier, to impose fines on violators of around $70 per violation.

In the United States, the Transportation Security Administration (TSA) is responsible for ensuring the safety of air travel. 

As of June 19, 2025, TSA regulations are designed to protect passengers and airline staff by minimizing potential threats at airports and on flights.

The TSA's Secure Flight is a risk-based passenger prescreening program that enhances security by identifying low- and high-risk passengers before they arrive at the airport, matching their names against trusted traveler lists and watchlists.

The TSA has reported that in June 2025, over 2.6 million people flew an airplane each day in the U.S.

Jun 19, 2025 • 8:35 am CDT
Costa Rica Travel data June 2025

While the Republic of Costa Rica's Ministry of Health is a leader in disclosing mosquito-transmitted disease cases, the information may be contributing to the decline of tourism in this Central American country.

 As of June 19, 2025, the Costa Rican Tourism Institute (ICT) data indicate that, since September 2024, eight of the last twelve months have seen fewer visitors.

For example, there was a 4.7% drop in air arrivals compared to May 2024.

The positive news from the ICT sector is that it projects a 2–4% growth for the remainder of 2025; however, challenges such as rising costs and safety concerns remain. 

As do reports of chikungunya, dengue, malaria, and even Zika cases in the mountains and beaches in 2025.

Furthermore, since April 2024, the Ministry of Health has reported a whooping cough outbreak in the Tibas district of San José.

According to the U.S. Centers for Disease Control and Prevention and the UK's Fit for Travel, visitors to Costa Rica may be exposed to mosquito-transmitted infectious diseases. As of June 19, 2025, the CDC recommends checking the travel vaccine list and seeing a healthcare provider at least a month before visiting Costa Rica.

Jun 19, 2025 • 5:24 am CDT
Google Maps June 19, 2025

According to a recent statement by Edivilson Brum, the head of the Rio Grande do Sul state’s agriculture department, Brazil is poised to declare commercial flocks free of the avian influenza (bird flu) virus.

The 28-day countdown for reclaiming Brazil's disease-free status began on May 22, 2025.

According to a government article, the 28-day sanitary quarantine ended on June 18, 2025, a period technically referred to as a sanitary vacuum.

Over the period, more than 4,000 vehicles were stopped at sanitary checkpoints set up in the region to control the transportation of animals, animal products, and feed. Surveillance visits to rural properties were conducted within two established zones: one located three kilometers away and the other ten kilometers from the outbreak.

With the end of restrictions and the absence of new outbreaks, Brazil will be able to declare itself to the WHO as a country free of highly pathogenic avian influenza, a crucial step in maintaining international confidence and strengthening Brazilian exports of poultry products.

Although the quarantine has ended, health surveillance remains active in Rio Grande do Sul, which is home to one of the largest poultry farms in Brazil.

All measures adopted in Montenegro followed national protocols and guidelines from the World Organization for Animal Health.

Jun 18, 2025 • 5:29 pm CDT
by Florian Pircher

In anticipation of next week’s meeting of the Centers for Disease Control and Prevention (CDC) vaccine advisory panel, a draft agenda was posted today.

The Advisory Committee on Immunization Practices (ACIP) draft agenda, released on June 18, 2025, reflects a shortened two-day meeting that is open to the public to attend digitally and, if selected, to ask questions.

The agenda includes presentations on COVID-19, RSV, Chikungunya, and other vaccines.

It also includes discussions focused on thimerosal as a vaccine ingredient and the measles, mumps, rubella, and varicella (MMRV) vaccine in children. Thimerosal is a mercury-based vaccine preservative for multidose vials.

In July 1999, the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal should be reduced or eliminated in vaccines as a precautionary measure.

Currently, only a limited number of flu vaccines contain the preservative.

Last week, the CDC’s 17-member ACIP was reduced to eight new members.

Jun 18, 2025 • 11:30 am CDT
Maps June 18, 2025

The UK Health Security Agency (UKHSA) today announced that a woman from Barnsley, South Yorkshire, diagnosed at Barnsley Hospital, has died after becoming infected with rabies, following contact with a stray dog during a visit to the Kingdom of Morocco, located in northern Africa.

Currently, the UK's list of rabies-risk areas does not include Monaco.

The UKHSA stated on June 18, 2025, that there is no risk to the broader public about this case, as there is no documented evidence of rabies transmission between people in England. Rabies virus is transmitted through bites and scratches from an infected animal.

Once infected, rabies is nearly always fatal.

Furthermore, rabies does not circulate in either wild or domestic animals in the United Kingdom; however, some species of bats can carry a rabies-like virus, as is the case in the United States. 

Dr. Katherine Russell, Head of Emerging Infections and Zoonoses, at UKHSA, commented in a press release, "If you are bitten, scratched or licked by an animal in a country where rabies is found then you should wash the wound or site of exposure with plenty of soap and water and seek medical advice without delay to get post-exposure treatment to prevent rabies."

When administered promptly after exposure, a course of rabies post-exposure treatment is highly effective in preventing the disease. If such an exposure occurs abroad, the traveller should also consult their doctor on return.

The UKHSA and the U.S. CDC suggest that international travelers speak with a travel vaccine consultant regarding rabies immunization options.

As of 2025, the WHO has pre-qualified human rabies vaccines, including Bavarian Nordic's RabAvert vaccine, which is commercially available in the United States.

 

Jun 18, 2025 • 6:01 am CDT
by Abigailj Thompson

GSK plc recently announced that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to India-based Bharat Biotech International Limited (BBIL).

This agreement paves the way for the ongoing development and potential distribution of the vaccine in low- and middle-income countries where Shigella, an acute human infection of the large intestine, is the leading bacterial cause of diarrhoea, posing a significant health threat to children under five.

The urgent challenge posed by increasing antimicrobial-resistant enteric bacteria, including Shigella, highlights the broader impact a vaccine could have beyond helping to reduce illness and mortality rates.

If approved, a Shigella vaccine has the potential to indirectly reduce antibiotic consumption and help combat the rise of antimicrobial resistance.

As of June 18, 2025, there are no U.S. Food and Drug Administration (FDA)- approved Shigella vaccines.

Thomas Breuer, Chief Global Health Officer at GSK, stated in a press release, "With young children in lower-income countries disproportionately impacted by Shigella, the development of a low-cost vaccine is an important goal for global public health."

Following the technology transfer, GSK will collaborate with BBIL on its design of the Phase 3 trial and support BBIL's efforts to secure external funding. This collaboration builds on GSK's existing relationship with the Indian Biotech company, following a product transfer and license agreement in 2021 for the world's first malaria vaccine, RTS,S (Mosquirix™).

Currently, Valneva SE and LimmaTech Biologics AG are co-developing the Shigella4V2 second-generation tetravalent bioconjugate vaccine candidate against shigelllosis, which is progressing in clinical trials.

Jun 18, 2025 • 5:00 am CDT
US CDC

Local media reported that Bahamian Health Minister Michel Darville announced that The Bahamas is preparing to cancel its contracts with Cuban health professionals.

According to Reuters on June 16, 2025, the reason for the cancellation is that negotiations are underway with the US government.

The NGO Archivo Cuba has reported that Cuban specialist medical advisors in the Bahamas were paid $12,000 per month, while biomedical engineers received $$5,000. 

As of June 16, 2025, the U.S. CDC says 'check the vaccines, such as measles or typhoid, and medicines list, and visit your doctor at least a month before your trip to The Bahamas. 

Previously, the U.S. and Canadian governments issued travel advisories regarding jet ski activities in the Bahamas. 

Jun 17, 2025 • 4:03 pm CDT
Google Maps June 17, 2025

France's Chikungunya outbreak, centered in the Indian Ocean, may be connected to the recent reporting of locally acquired cases adjacent to the Mediterranean coast.

A press release from the Occitanie Regional Health Agency, issued on June 16, 2025, confirmed a locally transmitted Chikungunya case in the Hérault Department. 

Since the beginning of May 2025, the Agency has reported 59 travel-related cases in Occitanie.

This Department includes the city of Montpellier, home to about 800,000 people.

The Agency wrote that anyone 'who have visited this town and who have shown signs suggestive of chikungunya since the beginning of May are invited by the ARS to consult their doctor.'

Recently, an indigenous (locally) Chikungunya case was reported in La Crau (Var) on June 11, 2025.

During 2024, over 20 travel-related cases were reported in France, and one local case in Île-de-France (Paris).

If your plans include visiting areas affected by the Chikungunya outbreak in 2025, the French and US health agencies recommend discussing vaccination options with a travel vaccination expert.

Currently, Chikungunya vaccines are approved by various countries and offer a high degree of protection from this mosquito-transmitted disease.

Jun 17, 2025 • 8:28 am CDT
Jubilee of Sport 2025

The Holy Father today urged all young people to participate in the great Jubilee event, dedicated specially to them, as it will be a unique and unforgettable week of celebration, spirituality, reconciliation, and sharing.

On June 15, 2025, Pope Leo XIV addressed a large gathering of children, young people, and adults who had come to Rome for the Jubilee of Sport.

This year's Jubilee will take place from July 28 to August 3, 2025, in Rome, Italy.

Following the first Jubilee of 1300, Pope Boniface VIII established the frequency of Jubilee celebrations as every 100 years. Following a plea from the people of Rome to Pope Clement VI, the frequency was reduced to every 50 years.

After the annexation of Rome to the Kingdom of Italy, the Jubilees were resumed in 1875.

According to the European CDC, no infectious disease events of relevance to the EU/EEA were detected during the Jubilee from June 9 to June 13, 2025.

The ECDC states that the probability of EU/EEA citizens contracting communicable diseases during the Jubilee 2025 is low if general preventive measures are implemented.

Jun 17, 2025 • 6:47 am CDT
Faunieqjohnna 2025

While Rabies is a rare disease, it remains a severe viral infection once symptoms appear. Thousands of people die each year from Rabies, mainly in Asia and Africa, with 40% of the cases being children.

According to the World Health Organization (WHO), travellers visiting rabies-endemic areas must be aware of the risk and know what to do if they are bitten or scratched.

WHO estimates that dogs are the primary source of human rabies deaths, causing up to 99% of all transmissions.

European travellers have been amongst those affected, including in June 2025, Spain confirmed a rabies case in a traveller who a dog in Ethiopia had bitten.

However, in the United States, bat bites are responsible for the majority of rabies cases in humans.

In March 2025, a bat found in northern Person County, North Carolina, tested positive for Rabies, marking the second confirmed case in Person County this year.

To reduce the risk of Rabies in Texas, the Department of State Health Services conducts the annual Oral Rabies Vaccination Program bait drop for animals. In its 31st year, this program has proven to be an effective defense against the spread of domestic dog and coyote rabies, as well as the Texas gray fox variant.

From a prevention perspective, two types of vaccines protect people against Rabies: nerve tissue and cell culture vaccines.

As of June 17, 2025, rabies vaccination services are offered at travel clinics and pharmacies, but are only recommended for specific travelers.